Earnings · Nov 4, 2026

Medline raises full-year organic sales guidance to 10%-10.5% and authorizes $1B buyback

MDLNMedline Inc.

Medline reported third-quarter net sales of $7.9 billion, up 10.4%, and raised its full-year 2026 organic sales growth outlook to 10.0%-10.5%. The company also announced a new $1 billion share repurchase program and prepaid $750 million on its term loan facility. Medline is the largest provider of medical-surgical products and supply chain solutions.